The New England Journal of Medicine

Last updated

History

In September 1811, Boston physician John Collins Warren, [3] along with James Jackson, submitted a formal prospectus to establish the New England Journal of Medicine and Surgery and Collateral Branches of Science as a medical and philosophical journal. [4] Subsequently, the first issue of the New England Journal of Medicine and Surgery and the Collateral Branches of Medical Science was published in January 1812. [5] The journal was published quarterly. [6]

In 1823, another publication, the Boston Medical Intelligencer, appeared under the editorship of Jerome V. C. Smith. [7]

The editors of the New England Journal of Medicine and Surgery and the Collateral Branches of Medical Science purchased the weekly Intelligencer for $600 in 1828, [8] merging the two publications to form the Boston Medical and Surgical Journal, and shifting from quarterly to weekly publication. [9]

In 1921, the Massachusetts Medical Society purchased the Journal for US$1 [10] (equivalent to $17in 2023) and, in 1928, renamed it to The New England Journal of Medicine. [11]

The journal's logo depicts the snake-wrapped Rod of Asclepius crossed over a quill pen. The dates on the logo represent the founding of the components of The New England Journal of Medicine: 1812 for the New England Journal of Medicine and Surgery and Collateral Branches of Medical Science, 1823 for the Boston Medical Intelligencer, 1828 for the Boston Medical and Surgical Journal, and 1928 for the New England Journal of Medicine. [12]

Notable articles

Notable articles from the course of The New England Journal of Medicine's history include:

Social media

On April 25, 1996, the NEJM announced a new web site, which published each week the abstracts for research articles and the full text of editorials, cases, and letters to the editor. After print publishing for 184 years this was the NEJM's first use of the Internet for electronic publication. [30]

The site was launched several months earlier in 1996, but the editors wanted proof that weekly electronic publication would work. Only then was an announcement approved for publication on the editorial page. In 1997, the website included prepublication releases of certain articles prior to their print publication. [31] In 1998, online publication extended to include the full text of all its articles from 1993 forward. [32]

Since its launch, NEJM has added to its site: [33]

Influence

The George Polk Awards site noted that its 1977 award to The New England Journal of Medicine: "...provided the first significant mainstream visibility for a publication that would achieve enormous attention and prestige in the ensuing decades." [36]

The journal usually has the highest impact factor of the journals of internal medicine. According to the Journal Citation Reports, NEJM had a 2017 impact factor of 79.258, [37] ranking it first of 153 journals in the category "General & Internal Medicine". [38] It was the only journal in the category with an impact factor of more than 70. By comparison, the second and third ranked journals in the category ( The Lancet and JAMA) had impact factors of 53.254 and 47.661 respectively. [39]

Theodore Dalrymple feels that this influence is unwarranted. In False Positive: A Year of Error, Omission, and Political Correctness in the New England Journal of Medicine, he examines various articles on medical and social issues that the NEJM published over the course of a year. He found that many arrived at conclusions which were not supported by the evidence presented, or ignored easily available evidence that contradicted their conclusions. [40]

Specialty journals

In 2022, NEJM set up a new sub-journal, NEJM Evidence. NEJM Evidence is a monthly digital journal featuring original research. It focuses on clinical trials and decision making.

Ingelfinger rule

The New England Journal of Medicine requires that articles it publishes have not been published or released elsewhere. Referred to as the Ingelfinger rule, the policy is intended to protect newsworthiness, and to subject research to peer review "before it is touted to the public or the profession". [41] By 1991, four types of exceptions were recognized, including when "prepublication release of research conclusions is warranted because of immediate implications for the public health". [42]

The rule was first described in a 1969 editorial, "Definition of Sole Contribution", by Franz Ingelfinger, the editor-in-chief at that time. [41] [43] A number of medical journals have similar rules in place. [44] [45]

Vioxx correction controversy

In the early 2000s, The New England Journal of Medicine was involved in a controversy around problems with research on the drug Vioxx. A study was published in the journal in November 2000 which noted an increase in myocardial infarction amongst those taking Vioxx. [46] According to Richard Smith, the former editor of the British Medical Journal , concerns about the correctness of that study were raised with the journal's editor, Jeff Drazen, as early as August 2001. That year, both the US Food and Drug Administration and the Journal of the American Medical Association also cast doubt on the validity of the data interpretation that had been published in the NEJM. [47] Merck withdrew the drug from market in September 2004. In December 2005, NEJM published an expression of concern about the original study following discovery that the authors knew more about certain adverse events than they disclosed at the time of publication. From the Expression of Concern: "Until the end of November 2005, we believed that these were late events that were not known to the authors in time to be included in the article published in the Journal on November 23, 2000. It now appears, however, from a memorandum dated July 5, 2000, that was obtained by subpoena in the Vioxx litigation and made available to the Journal, that at least two of the authors knew about the three additional myocardial infarctions at least two weeks before the authors submitted the first of two revisions and 4 1/2 months before publication of the article." [48] During the five-year period between publication and Expression of Concern, it has been estimated that Merck paid NEJM as much as US$836,000 for article reprints that Merck used for promotional purposes. [49] The journal was publicly rebuked for its response to the research issues in editorials appearing in publications including the British Medical Journal [47] and the Journal of the Royal Society of Medicine . [50]

Open access policy

NEJM makes articles that meet the criteria for global and public health importance freely available to all readers upon publication at NEJM.org. NEJM also partners with Research4Life in their Access to Research in Health (Hinari) program to grant to low-income countries immediate free access to NEJM.org.

NEJM does not charge authors any submission or publication fees. NEJM also works with authors whose articles report research supported by funding bodies with open access mandates, including (but not limited to) Plan S funders and the U.S. government, including NIH, to ensure that authors are able to meet their funders’ requirements for public access to research results.

For research articles submitted before February 1, 2024, NEJM makes the full-text Version of Record available at NEJM.org six months after publication. For research articles submitted on or after February 1, 2024, NEJM will provide authors with a PDF file of the Author Accepted Manuscript that may be deposited in a noncommercial repository after publication. [51]

NEJM also has two podcast features, one with interviews of doctors and researchers that are publishing in the journal, and another summarizing the content of each issue. Other offerings include Continuing Medical Education, Videos in Clinical Medicine (showing videos of medical procedures), and the weekly Image Challenge.

Editors

See also

Related Research Articles

<span class="mw-page-title-main">Randomized controlled trial</span> Form of scientific experiment

A randomized controlled trial is a form of scientific experiment used to control factors not under direct experimental control. Examples of RCTs are clinical trials that compare the effects of drugs, surgical techniques, medical devices, diagnostic procedures, diets or other medical treatments.

<i>The BMJ</i> British peer-reviewed medical journal

The BMJ is a weekly peer-reviewed medical journal, published by BMJ Group, which in turn is wholly-owned by the British Medical Association (BMA). The BMJ has editorial freedom from the BMA. It is one of the world's oldest general medical journals. Previously called the British Medical Journal, the title was officially shortened to BMJ in 1988, and then changed to The BMJ in 2014. The journal is published by BMJ Publishing Group Ltd, a subsidiary of the British Medical Association (BMA). The current editor-in-chief of The BMJ is Kamran Abbasi, who was appointed in January 2022.

<span class="mw-page-title-main">Rofecoxib</span> Nonsteroidal anti-inflammatory drug

Rofecoxib is a COX-2-selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea. Rofecoxib was approved in the US by the US Food and Drug Administration (FDA) in May 1999, and was marketed under the brand names Vioxx, Ceoxx, and Ceeoxx. Rofecoxib was available by prescription in both tablets and as an oral suspension.

<i>Canadian Medical Association Journal</i> Peer-reviewed general medical journal

The Canadian Medical Association Journal is a peer-reviewed open-access general medical journal published by the Canadian Medical Association. It publishes original clinical research, analyses and reviews, news, practice updates, and editorials.

Science by press conference or science by press release is the practice by which scientists put an unusual focus on publicizing results of research in the news media via press conferences or press releases. The term is usually used disparagingly, to suggest that the seekers of publicity are promoting claims of questionable scientific merit, using the media for attention as they are unlikely to win the approval of the scientific community.

<span class="mw-page-title-main">News embargo</span> Tactic for delaying publication by the press of a news item

In journalism and public relations, a news embargo or press embargo is a request or requirement by a source that the information or news provided by that source not be published until a certain date or certain conditions have been met. They are often used by businesses making a product announcement, by medical journals, and by government officials announcing policy initiatives; the media is given advance knowledge of details being held secret so that reports can be prepared to coincide with the announcement date and yet still meet press time.

<span class="mw-page-title-main">Medical literature</span> Scientific literature of medicine

Medical literature is the scientific literature of medicine: articles in journals and texts in books devoted to the field of medicine. Many references to the medical literature include the health care literature generally, including that of dentistry, veterinary medicine, pharmacy, nursing, and the allied health professions.

<span class="mw-page-title-main">Marcia Angell</span> American physician and academic (born 1939)

Marcia Angell is an American physician, author, and the first woman to serve as editor-in-chief of the New England Journal of Medicine. She is currently a Senior Lecturer in the Department of Global Health and Social Medicine at Harvard Medical School in Boston, Massachusetts.

<span class="mw-page-title-main">Arnold S. Relman</span> American internist, professor and journal editor (1923–2014)

Arnold Seymour Relman — known as Bud Relman to intimates — was an American internist and professor of medicine and social medicine. He was editor of The New England Journal of Medicine (NEJM) from 1977 to 1991, where he instituted two important policies: one asking the popular press not to report on articles before publication and another requiring authors to disclose conflicts of interest. He wrote extensively on medical publishing and reform of the U.S. health care system, advocating non-profit delivery of single-payer health care. Relman ended his career as professor emeritus at Harvard Medical School in Boston, Massachusetts.

<span class="mw-page-title-main">Peter Pronovost</span> American physician

Peter J. Pronovost is Chief Quality and Transformation Officer at University Hospitals Cleveland Medical Center, the main affiliate of the Case Western Reserve University School of Medicine.

Franz Joseph Ingelfinger was a German-American physician, researcher and journal editor. He served as Chief of Gastroenterology at Evans Memorial Department of Clinical Research, part of Boston University School of Medicine. He also served as Editor of the New England Journal of Medicine (NEJM) from 1967 to 1976. His work was influential in the field of science journalism.

The Ingelfinger rule is an eponymous rule named after Franz J. Ingelfinger, the The New England Journal of Medicine (NEJM) editor-in-chief who enunciated it in 1969. Editorials in most journals were published anonymously that time, so the paper was published without an author's name.. This rule - basically meant for scientific publishing, was originally meant only for NEJM. The rule was, that NEJM would not publish findings that had been published elsewhere, in other media or in other journals. The rule was subsequently adopted by several other scientific journals, and has shaped scientific publishing ever since. Historically it has also helped to ensure that the journal's content is fresh and does not duplicate content previously reported elsewhere, and seeks to protect the scientific embargo system.

<span class="mw-page-title-main">Anthony L. Komaroff</span> American physician

Anthony L. Komaroff is an American physician, clinical investigator, editor, and publisher. He serves as the Distinguished Simcox-Clifford-Higby Professor of Medicine at Harvard Medical School and Senior Physician at Brigham and Women's Hospital in Boston.

Dr. Kodaganur S. Gopinath, MS, FAMS, FRCS (Edin) is an Indian surgical oncologist, known for his pioneering work on oncological research. He is a recipient of many awards including Dr. B. C. Roy Award, considered to be the premier medical honour in the country. The President of India recognised his services to the field of oncology, by awarding him the fourth highest civilian award, Padma Shri, in 2010.

Mandeep R. Mehra is The William Harvey Distinguished Chair in Advanced Cardiovascular Medicine and a professor of medicine at Harvard Medical School. He is the medical director of the Brigham Heart and Vascular Center in Boston, Massachusetts, and specializes in advanced heart failure, mechanical circulatory support and cardiac transplantation.

<span class="mw-page-title-main">Conflicts of interest in academic publishing</span>

Conflicts of interest (COIs) often arise in academic publishing. Such conflicts may cause wrongdoing and make it more likely. Ethical standards in academic publishing exist to avoid and deal with conflicts of interest, and the field continues to develop new standards. Standards vary between journals and are unevenly applied. According to the International Committee of Medical Journal Editors, "[a]uthors have a responsibility to evaluate the integrity, history, practices and reputation of the journals to which they submit manuscripts".

Surgisphere is an American healthcare analytics company established in 2008 by Sapan Desai. Originally a textbook marketing company, it came under scrutiny in May 2020 after it provided large datasets of COVID-19 patients that were subsequently found to be unreliable. The questionable data were used in studies published in The Lancet and The New England Journal of Medicine in May 2020, suggesting that COVID-19 patients on hydroxychloroquine had a "significantly higher risk of death". In light of these studies, the World Health Organization decided to temporarily halt global trials of the drug hydroxychloroquine to treat COVID-19. After the studies were retracted, the WHO trials were resumed and then discontinued shortly after.

<span class="mw-page-title-main">John Ware (physician)</span> American physician and academic

John Ware was an American physician, college professor, and editor. He was a professor at Harvard University from 1832 to 1858. He was a founding member of the Boston Society of Natural History and fellow of the American Academy of Arts and Sciences.

Joseph Garland (1893–1973) was an American pediatrician and editor of The New England Journal of Medicine.

Donald Redelmeier, M.D., M.S., FRCPC, FACP is a Canadian internist, the Canada Research Chair in Medical Decision Sciences and a Professor of Medicine at the University of Toronto. He is most well known for a seminal New England Journal of Medicine paper in 1997 connecting cellphone use and motor vehicle accidents, which has led to laws banning the use of cellphones while driving across the world. He is also known for his work on the peak–end rule and duration neglect. A recent publication showing an increased rate of motor vehicle accidents in patients who refuse vaccination was featured on media outlets around the world.

References

  1. ↑ Zuger, Abigail (March 19, 2012). "A journal stands out in prestige and longevity". The New York Times . Retrieved June 24, 2014.
  2. ↑ "Web of Science Master Journal List - WoS MJL by Clarivate". mjl.clarivate.com. Retrieved 2024-07-24.
  3. ↑ Cary, John (1961). Joseph Warren: Physician, Politician, Patriot . Urbana: University of Illinois Press. OCLC   14595803.
  4. ↑ Boston Patriot . September 28, 1811
  5. ↑ "January 1, 1812, table of contents for the New England Journal of Medicine and Surgery and the Collateral Branches of Medical Science" . Retrieved 2011-12-22.
  6. ↑ "About NEJM: Past and Present". nejm.org. New England Journal of Medicine. Retrieved 2021-08-31. ...publishing the first quarterly edition of the New England Journal of Medicine and Surgery and the Collateral Branches of Medical Science (Boston) in January of 1812.
  7. ↑ Fitz-Gilbert Waters, Henry (1894). The New England Historical and Genealogical Register. Vol. 48. New England Historic Genealogical Society. pp. 148–149.
  8. ↑ Garland, Joseph (1952). "The New England Journal of Medicineand the Massachusetts Medical Society". New England Journal of Medicine. 246 (21): 801–806. doi:10.1056/NEJM195205222462101. PMID   14929322.
  9. ↑ Campion, Edward W.; Miller, Pamela W.; Costello, Jean; Duff, Ellen; Drazen, Jeffrey M. (2010). "The Journal from 1812 to 1989 at NEJM.org". New England Journal of Medicine. 363 (12): 1175–1176. doi: 10.1056/NEJMe1009367 . PMID   20843253.
  10. ↑ "About NEJM: Past and Present". nejm.org. New England Journal of Medicine. Retrieved 2021-08-31. In 1921, the journal merged with the Boston Medical Intelligencer to become the Boston Medical and Surgical Journal; it also began weekly publication that year and was purchased by the Massachusetts Medical Society for $1.
  11. ↑ "About NEJM: Past and Present". nejm.org. New England Journal of Medicine. Retrieved 2021-08-31. Renamed to the New England Journal of Medicine in 1928, the journal is known for many firsts in medicine, ....
  12. ↑ Kassirer, Jerome P. (1996). "The Journal's New Look". New England Journal of Medicine. 335: 50–51. doi: 10.1056/NEJM199607043350110 . S2CID   75449829.
  13. ↑ "History of Anesthesia". Wood Library-Museum of Anesthesiology. Retrieved 2024-07-08.
  14. ↑ Bigelow, Henry Jacob (1846). "Insensibility during surgical operations produced by inhalation". The Boston Medical and Surgical Journal. 35 (16): 309–317. doi:10.1056/NEJM184611180351601. S2CID   46290593.
  15. ↑ Wright, James Homer (1906). "The origin and nature of the blood plates". The Boston Medical and Surgical Journal. 154 (23): 643–645. doi:10.1056/NEJM190606071542301.
  16. ↑ Brown-Sequard, C.E.; Webber, S.G. (1872). "The origin and signification of the symptoms of brain disease". The Boston Medical and Surgical Journal. 87 (16): 261–263. doi:10.1056/NEJM187210170871601.
  17. ↑ Farber, Sidney; Diamond, Louis K.; Mercer, Robert D.; Sylvester, Robert F.; et al. (1948). "Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)". New England Journal of Medicine. 238 (23): 787–793. doi:10.1056/NEJM194806032382301. PMID   18860765.
  18. ↑ Zoll, PM (November 1952). "Resuscitation of the heart in ventricular standstill by external electric stimulation". New England Journal of Medicine. 247 (20): 768–771. doi:10.1056/NEJM195211132472005. PMID   13002611.
  19. ↑ Wolff, William I.; Shinya, Hiromi (1973). "Polypectomy via the fiberoptic colonoscope". New England Journal of Medicine. 288 (7): 329–332. doi:10.1056/NEJM197302152880701. PMID   4682941.
  20. ↑ Porter, J.; Jick, H. (1980). "Addiction Rate in Patients Treated with Narcotics". New England Journal of Medicine. 302 (2): 123. doi: 10.1056/NEJM198001103020221 . PMID   7350425.
  21. ↑ "Opioid crisis: The letter that started it all". BBC News . June 3, 2017. Retrieved June 3, 2017.
  22. ↑ Gottlieb, Michael S.; Schroff, Robert; Schanker, Howard M.; Weisman, Joel D.; et al. (1981). "Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men". New England Journal of Medicine. 305 (24): 1425–1431. doi:10.1056/NEJM198112103052401. PMID   6272109.
  23. ↑ Masur, Henry; Michelis, Mary Ann; Greene, Jeffrey B.; Onorato, Ida; et al. (1981). "An outbreak of community-acquired Pneumocystis carinii pneumonia". New England Journal of Medicine. 305 (24): 1431–1438. doi:10.1056/NEJM198112103052402. PMID   6975437.
  24. ↑ Druker, Brian J.; Talpaz, Moshe; Resta, Debra J.; Peng, Bin; et al. (2001). "Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia". New England Journal of Medicine. 344 (14): 1031–1037. doi: 10.1056/NEJM200104053441401 . PMID   11287972. S2CID   8399298.
  25. ↑ Kolata, Gina (7 October 2020). "In a First, New England Journal of Medicine Joins Never-Trumpers". The New York Times. Retrieved October 8, 2020.
  26. ↑ Carhart-Harris, Robin; Giribaldi, Bruna; Watts, Rosalind; Baker-Jones, Michelle; Murphy-Beiner, Ashleigh; Murphy, Roberta; Martell, Jonny; Blemings, Allan; Erritzoe, David; Nutt, David J. (2021-04-14). "Trial of Psilocybin versus Escitalopram for Depression". New England Journal of Medicine. 384 (15): 1402–1411. doi: 10.1056/NEJMoa2032994 . ISSN   0028-4793. PMID   33852780. S2CID   233243518.
  27. ↑ Sloat, Sarah (18 April 2021). "Scientist compared psilocybin against antidepressants for the first time". Inverse. Retrieved 2021-05-24.
  28. ↑ "Psychedelic drug worked for depression as well as common antidepressant, small trial finds". NBC News. 14 April 2021. Retrieved 2021-05-24.
  29. ↑ Siebert, Amanda. "Could Psilocybin Treat Depression? New Head-To-Head Trial Shows It's At Least As Effective As Leading SSRI". Forbes. Retrieved 2021-05-24.
  30. ↑ Campion, Edward W. (1996). "The Journal's new presence on the internet". New England Journal of Medicine. 334 (17): 1129. doi: 10.1056/NEJM199604253341712 .
  31. ↑ Kassirer, Jerome P.; Angell, Marcia (1997). "Prepublication Release of Journal Articles". New England Journal of Medicine. 337 (24): 1762–1763. doi: 10.1056/NEJM199712113372409 . PMID   9392703.
  32. ↑ Campion, Edward W. (1998). "Improvements to the Journal's Site on the World Wide Web". New England Journal of Medicine. 339 (9): 629. doi: 10.1056/NEJM199808273390912 . PMID   9718386.
  33. 1 2 "The New England Journal of Medicine Celebrates 200th Anniversary in 2012" (Press release). Business Wire. January 12, 2012. Archived from the original on 2021-09-28. Retrieved 2021-09-27.
  34. ↑ McMahon, Graham T.; Ingelfinger, Julie R.; Campion, Edward W. (2006). "Videos in clinical medicine – A new Journal feature". New England Journal of Medicine. 354 (15): 1635. doi: 10.1056/NEJMe068044 .
  35. ↑ McMahon, Graham T.; Solomon, Caren G.; Ross, John J.; Loscalzo, Joseph; et al. (2009). "Interactive medical cases – A new Journal feature". New England Journal of Medicine. 361 (11): 1113. doi: 10.1056/NEJMe0809756 .
  36. ↑ Hershey, Edward. "A history of journalistic integrity, superb reporting and protecting the public: The George Polk Awards in Journalism". LIU Brooklyn. Archived from the original on March 28, 2010.
  37. ↑ "Media Center: Fact Sheet". nejm.org. Massachusetts Medical Society. Retrieved August 20, 2014.
  38. ↑ "Rank in Category: New England Journal of Medicine". 2017 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.
  39. ↑ "Journals Ranked by Impact: Medicine, General & Internal". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.
  40. ↑ Dalrymple, Theodore (2019). False Positive: A Year of Error, Omission, and Political Correctness in the New England Journal of Medicine. Encounter. p. 272. ISBN   978-1641770460.
  41. 1 2 Relman, Arnold S. (1981). "The Ingelfinger Rule". New England Journal of Medicine. 305 (14): 824–826. doi: 10.1056/NEJM198110013051408 . PMID   7266634.
  42. ↑ Angell, Marcia; Kassirer, Jerome P. (1991). "The Ingelfinger Rule Revisited". New England Journal of Medicine. 325 (19): 1371–1373. doi: 10.1056/NEJM199111073251910 . PMID   1669838.
  43. ↑ "Definition of Sole Contribution". New England Journal of Medicine. 281 (12): 676–677. 1969. doi: 10.1056/NEJM196909182811208 . PMID   5807917.
  44. ↑ Altman, L.K. (1996). "The Ingelfinger rule, embargoes, and journal peer review-part 1". The Lancet. 347 (9012): 1382–1386. doi: 10.1016/s0140-6736(96)91016-8 . PMID   8637347. S2CID   44524038.
  45. ↑ Kardas-Nelson, Mara (2020). "Covid-19's impact on US medical research—shifting money, easing rules". BMJ. 369: m1744. doi: 10.1136/bmj.m1744 . PMID   32357953. S2CID   218479874.
  46. ↑ VIGOR Study Group; Bombardier, C.; Laine, L.; Reicin, A.; et al. (2000). "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis". New England Journal of Medicine. 343 (21): 1520–1528. doi: 10.1056/NEJM200011233432103 . PMID   11087881.
  47. 1 2 Dobson, Roger (July 15, 2006). "NEJM "failed its readers" by delay in publishing its concerns about VIGOR trial". BMJ. 333 (7559): 116. doi:10.1136/bmj.333.7559.116-f. PMC   1502213 . PMID   16840463.
  48. ↑ Curfman, Gregory D.; Morrissey, Stephen; Drazen, Jeffrey M. (2005). "Expression of Concern: Bombardier et al., "Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis," N Engl J Med 2000;343:1520-8". New England Journal of Medicine. 353 (26): 2813–2814. doi: 10.1056/NEJMe058314 . PMID   16339408. S2CID   10745161.
  49. ↑ Lemmens, Trudo; Bouchard, Ron A. (2007). "Regulation of Pharmaceuticals in Canada"". In Downie, Jocelyn; Caulfield, Timothy A.; Flood, Colleen M. (eds.). Canadian Health Law and Policy (3rd ed.). Toronto: LexisNexis Canada. p. 336. ISBN   9780433452218.
  50. ↑ Smith, Richard (August 2006). "Lapses at The New England Journal of Medicine" (PDF). Journal of the Royal Society of Medicine (editorial). 99 (8): 380–382. doi:10.1177/014107680609900802. PMC   1533509 . PMID   16893926 . Retrieved May 22, 2010.
  51. ↑ "Editorial Policies". nejm.org. Massachusetts Medical Society. Retrieved February 15, 2024.

Bibliography

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.